Schroder Investment Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-82,358
Closed -$14.7M 1381
2020
Q1
$14.7M Sell
82,358
-20,105
-20% -$3.79M 0.03% 444
2019
Q4
$19.6M Sell
102,463
-93,232
-48% -$16.8M 0.03% 494
2019
Q3
$32.9M Buy
195,695
+29,786
+18% +$4.85M 0.06% 347
2019
Q2
$27.8M Buy
165,909
+87,471
+112% +$12.1M 0.05% 376
2019
Q1
$11.5M Buy
78,438
+18,955
+32% +$2.75M 0.02% 561
2018
Q4
$7.95K Buy
59,483
+94
+0.2% +$15.4K 0.01% 603
2018
Q3
$11.3M Sell
59,389
-84,878
-59% -$15.6M 0.02% 577
2018
Q2
$24.3M Buy
144,267
+35,203
+32% +$5.65M 0.04% 420
2018
Q1
$18.4M Sell
109,064
-198,156
-64% -$33.2M 0.03% 472
2017
Q4
$50.3M Sell
307,220
-112,073
-27% -$20.1M 0.08% 291
2017
Q3
$85.6M Buy
419,293
+5,341
+1% +$1.24M 0.15% 180
2017
Q2
$101M Sell
413,952
-3,996
-1% -$939K 0.18% 138
2017
Q1
$100M Buy
417,948
+238,796
+133% +$55.6M 0.18% 148
2016
Q4
$37.6M Buy
179,152
+132,308
+282% +$27.4M 0.07% 334
2016
Q3
$10.8M Buy
46,844
+6,331
+16% +$1.55M 0.02% 613
2016
Q2
$9.36M Sell
40,513
-41,695
-51% -$9.61M 0.02% 625
2016
Q1
$22.6M Sell
82,208
-20,534
-20% -$5.88M 0.05% 434
2015
Q4
$32.1M Buy
102,742
+5,700
+6% +$1.7M 0.07% 349
2015
Q3
$26.4M Buy
97,042
+10,161
+12% +$3.12M 0.06% 389
2015
Q2
$26.4M Sell
86,881
-9,208
-10% -$2.75M 0.05% 414
2015
Q1
$29.2M Sell
96,089
-27,690
-22% -$7.89M 0.06% 390
2014
Q4
$31.9M Buy
123,779
+87,768
+244% +$21.9M 0.06% 364
2014
Q3
$8.69M Buy
36,011
+16,911
+89% +$3.78M 0.01% 695
2014
Q2
$4.26M Hold
19,100
0.01% 790
2014
Q1
$3.93M Sell
19,100
-3,966
-17% -$786K ﹤0.01% 819
2013
Q4
$3.88M Buy
23,066
+10,451
+83% +$1.63M ﹤0.01% 844
2013
Q3
$1.82M Hold
12,615
﹤0.01% 932
2013
Q2
$1.59M Buy
+12,615
New +$1.43M ﹤0.01% 937

Other funds holding AGN

Schroder Investment Management Group's AGN Position: Q2 2020 in Review

Schroder Investment Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 82,358 shares — an estimated $14.7M sold.

Schroder Investment Management Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $101M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Schroder Investment Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 82,358 Allergan plc shares in Q2 2020, an estimated $14.7M.
  • Schroder Investment Management Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Schroder Investment Management Group's Allergan plc position peaked at $101M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Schroder Investment Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.